The
acute phase response, as a component of the innate immune system, is part of the first line of defense against invading pathogens. The Stimulator of
Interferon Genes (
STING) pathway initiates innate immune responses upon recognition of exogenous bacterial and
viral DNA. However, whether
STING signaling pathway plays any roles in regulating
acute phase response during
bacterial infection remains unknown. In this study, we used
STING-deficient (Tmem173gt) and wildtype mice to investigate
acute phase responses to
bacterial infection (Escherichia coli, E. coli) and test the effect of exogenous
cyclic GMP-AMP (
cGAMP, a
STING agonist) treatment.
Bacterial infection of
STING-deficient mice resulted in an increase in mortality and bacterial dissemination. Also,
inflammation-induced
acute phase response was drastically reduced in
STING-deficient mice, showing significant reduction in expression of
cytokine TNF-α and
acute phase proteins. In contrast, exogenous
cGAMP treatment enhanced
inflammation-induced
acute phase response by increasing the expression of TNF-α and
acute phase proteins. Also,
cGAMP accelerated bacterial clearance and improved survival rate of wildtype mice, but not
STING-deficient mice. Interestingly,
cGAMP treatment mitigated
bacterial infection induced liver injury in both wildtype and
STING-deficient mice. Further in vitro evidence showed that
cGAMP treatment retarded TNF-α-mediated hepatocyte apoptosis, potentially accelerating autophagy. Taken together, our results indicated that
cGAMP/
STING signaling pathway is critical for organism to initiate blood-borne innate immune-responses to defend
bacterial infection, and
cGAMP is envisaged as a
drug candidate for further clinical trial.